B. Parente

Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation

Carla Ribeiro, Sofia Campelos, Conceição Souto Moura et al. · Annals of Oncology · 2013 · 50 citations · Full text

Tumoral Pathology, Germline Bap1 Mutation, Well-differentiated Papillary Mesothelioma +5

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

Fabrice Barlési, Makoto Nishio, Manuel Cobo et al. · Annals of Oncology · 2018 · 49 citations

Key Subgroups, Oncology, Medicine +6

Undernutrition and quality of life in non small cell lung cancer patients

Sónia Xará, Teresa Amaral, B. Parente · Revista Portuguesa de Pneumologia · 2011 · 28 citations · Full text

An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer

António Araújo, B. Parente, Renato Sotto‐Mayor et al. · Revista Portuguesa de Pneumologia · 2008 · 23 citations · Full text

Epidermal Growth Factor Recetor mutation study for 5 years, in a population of patients with non-small cell lung cancer

Ana Castro, B. Parente, Ana Antunes et al. · Revista Portuguesa de Pneumologia · 2013 · 14 citations · Full text